NCT05364632 Aerobic Training Versus Behavioral Intervention to Increase Physical Activity in Patients With Asthma
| NCT ID | NCT05364632 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Sao Paulo General Hospital |
| Condition | Asthma |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2022-08-23 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2022-08-23 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare the effects of aerobic training and behavioural intervention to increase physical activity in the clinical control of asthma and in the quality of life of patients with asthma.
Eligibility Criteria
Inclusion Criteria: 1. Participants not physically active; 2. Uncontrolled asthma (ACQ\>1,5); 3. Diagnosis of asthma based on the recommendations of the Global Initiative for Asthma (GINA 2020); 4. Be under outpatient follow-up at the Pulmonology or Immunology service of the University of Sao Paulo General Hospital; 5. Be under outpatient medical treatment for at least six months, with a stable clinical condition for at least 30 days; 6. Being using optimized drug therapy for asthma. Exclusion Criteria: 1. Participation in another research protocol; 2. Difficulty in understanding any of the questionnaires used; 3. Practitioners of regular physical activity; 4. Pregnancy and psychiatric problems that make it difficult to understand the questionnaires and the study protocol; 5. Presence of another chronic lung, neurological or musculoskeletal disease that hinders or prevents physical activity; 6. Patients who are smokers or ex-smokers (who have quit smoking for less than 1 year or who have smoked more than 15 pack-years).
Contact & Investigator
Celso RF Carvalho, PhD
STUDY DIRECTOR
University of Sao Paulo General Hospital
Frequently Asked Questions
Who can join the NCT05364632 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05364632 currently recruiting?
Yes, NCT05364632 is actively recruiting participants. Contact the research team at cscarval@usp.br for enrollment information.
Where is the NCT05364632 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT05364632 clinical trial?
NCT05364632 is sponsored by University of Sao Paulo General Hospital. The principal investigator is Celso RF Carvalho, PhD at University of Sao Paulo General Hospital. The trial plans to enroll 56 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.